India hospital covid-19 medicines India

Covid drugs rescue earnings of pharma companies in Q1

Reading now: 205
www.livemint.com

Pharmaceutical companies with covid-19 drugs in their portfolios reported some of the best earnings in the June quarter, even as the overall medicine market was down as the lockdown disrupted services at hospital out-patient departments and elective surgeries.“All those who had some covid drugs did well, and those who had HCQ in their portfolio did extraordinarily well.

Ipca was the biggest gainer. They posted almost four-fold profit from HCQ. Alembic is India’s largest manufacturer of azithromycin.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA